1. |
Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA, 1992, 268(17): 2420-2425.
|
2. |
Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn't. BMJ, 1996, 312(7023): 71-72.
|
3. |
Richardson PE. David Sackett and the birth of evidence based medicine: how to practice and teach EBM. BMJ, 2015, 350: h3089.
|
4. |
Institute of Medicine (US) Committee on standards for developing trustworthy clinical practice guidelines; Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, editors. Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press (US); 2011.
|
5. |
张亮. 重症医学-十年循证带给我们的启示. 中华医学信息导报, 2012, 27(11): 12.
|
6. |
倪伟建, 方焱, 张善堂, 等. 基于药物基因组学与血药浓度监测指导的个体化用药研究. 中国医院药学杂志, 2018, 38(17): 1863-1868.
|
7. |
Moran S, Martinez-Cardús A, Boussios S, et al. Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary. Nat Rev Clin Oncol, 2017, 14(11): 682-694.
|
8. |
Howard SC, McCormick J, Pui CH, et al. Preventing and managing toxicities of high-dose methotrexate. Oncologist, 2016, 21(12): 1471-1482.
|
9. |
Mikkelsen TS, Thorn CF, Yang JJ, et al. Pharm GKB summary: methotrexate pathway. Pharmacogenet Genomics, 2011, 21(10): 679-686.
|
10. |
魏来临, 张岩, 邢冰. 疾病诊疗决策中如何具体融合患者的价值观. 医学与哲学(临床决策论坛版), 2008, (8): 1-2, 12.
|
11. |
李幼平, 李静, 孙鑫, 等. 循证医学在中国的起源与发展: 献给中国循证医学20周年. 中国循证医学杂志, 2016, 16(1): 2-6.
|
12. |
丁泓帆, 杨楠, 邓围, 等. WHO指南制定的基本原则和方法. 中国循证医学杂志, 2016, 16(4): 471-477.
|
13. |
Preference Collaborative Review Group. Patients' preferences within randomised trials: systematic review and patient level meta-analysis. BMJ, 2008, 337: a1864.
|
14. |
王明辉, 张菁, 曾宪涛, 等. 临床实践指南制订方法-患者的价值观和意愿. 中国循证心血管医学杂志, 2018, 10(10): 1153-1156, 1161.
|
15. |
解染, 徐晓涵, 陈恳, 等. 感染患者关于万古霉素治疗药物监测的价值观与意愿调查(英文). 药物流行病学杂志, 2016, (6): 390-395.
|
16. |
徐晓涵, 陈恳, 孙浩, 等. 真菌感染患者对伏立康唑个体化用药的意愿调查. 中国临床药理学杂志, 2017, 33(5): 456-458, 466.
|
17. |
Yang L, Hu X, Xu L. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis. Tumour Biol, 2012, 33(5): 1445-1454.
|
18. |
Lopez-Lopez E, Martin-Guerrero I, Ballesteros J, et al. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia. Pharmacogenomics J, 2013, 13(6): 498-506.
|
19. |
何霞. 还原叶酸载体基因多态性与大剂量甲氨蝶呤药物不良反应关系的Meta分析. 中国临床药理学杂志, 2016, 32(15): 1432-1434.
|
20. |
解染, 陈耀龙, 陈昊, 等. 循证指南制定中患者价值观和偏好的研究方法. 中国循证医学杂志, 2015, 15(5): 586-591.
|